InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Foster-Cheek Kaye I, Director. Director active across 2 companies, notably AGIOS PHARMACEUTICALS, INC.. In total, 3 filings have been recorded. The latest transaction was filed on 20 May 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations3 total
01,585 shares0
Common stock
SEC:0001439222-22-000048:0·
01,686 shares0
Common stock
SEC:0001439222-21-000053·
01,686 shares0
Common stock
SEC:0001439222-21-000053:0·
3 of 3 declarations
About Foster-Cheek Kaye I
Kaye I. Foster-Cheek is a Director at Agios Pharmaceuticals, Inc. She contributes to the governance of the company and strategic decision-making. Her expertise in the pharmaceutical sector allows her to provide valuable insights into regulatory and innovation challenges.
